These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 28865468)

  • 1. Brain ureido degenerative protein modifications are associated with neuroinflammation and proteinopathy in Alzheimer's disease with cerebrovascular disease.
    Gallart-Palau X; Serra A; Lee BST; Guo X; Sze SK
    J Neuroinflammation; 2017 Sep; 14(1):175. PubMed ID: 28865468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender differences in white matter pathology and mitochondrial dysfunction in Alzheimer's disease with cerebrovascular disease.
    Gallart-Palau X; Lee BS; Adav SS; Qian J; Serra A; Park JE; Lai MK; Chen CP; Kalaria RN; Sze SK
    Mol Brain; 2016 Mar; 9():27. PubMed ID: 26983404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of glutamate receptors in a novel in vitro model of early, comorbid cerebrovascular, and Alzheimer's diseases.
    Simões-Pires EN; Ferreira ST; Linden R
    J Neurochem; 2021 Feb; 156(4):539-552. PubMed ID: 32683713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Alzheimer's and Cerebrovascular Pathology in Mediating the Effects of Age, Race, and Apolipoprotein E Genotype on Dementia Severity in Pathologically-Confirmed Alzheimer's Disease.
    Gavett BE; John SE; Gurnani AS; Bussell CA; Saurman JL
    J Alzheimers Dis; 2016; 49(2):531-45. PubMed ID: 26444761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Levels of Extracellular Microvesicle Markers and Decreased Levels of Endocytic/Exocytic Proteins in the Alzheimer's Disease Brain.
    Musunuri S; Khoonsari PE; Mikus M; Wetterhall M; Häggmark-Mänberg A; Lannfelt L; Erlandsson A; Bergquist J; Ingelsson M; Shevchenko G; Nilsson P; Kultima K
    J Alzheimers Dis; 2016 Oct; 54(4):1671-1686. PubMed ID: 27636840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling the Relationships Among Late-Life Body Mass Index, Cerebrovascular Disease, and Alzheimer's Disease Neuropathology in an Autopsy Sample of 1,421 Subjects from the National Alzheimer's Coordinating Center Data Set.
    Alosco ML; Duskin J; Besser LM; Martin B; Chaisson CE; Gunstad J; Kowall NW; McKee AC; Stern RA; Tripodis Y
    J Alzheimers Dis; 2017; 57(3):953-968. PubMed ID: 28304301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer's disease beta-protein.
    Coria F; Castaño EM; Frangione B
    Am J Pathol; 1987 Dec; 129(3):422-8. PubMed ID: 3322021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The overlap between vascular disease and Alzheimer's disease--lessons from pathology.
    Attems J; Jellinger KA
    BMC Med; 2014 Nov; 12():206. PubMed ID: 25385447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass spectrometric identification of citrullination sites and immunohistochemical detection of citrullinated glial fibrillary acidic protein in Alzheimer's disease brains.
    Ishigami A; Masutomi H; Handa S; Nakamura M; Nakaya S; Uchida Y; Saito Y; Murayama S; Jang B; Jeon YC; Choi EK; Kim YS; Kasahara Y; Maruyama N; Toda T
    J Neurosci Res; 2015 Nov; 93(11):1664-74. PubMed ID: 26190193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic Profiling of Plasma and Brain Tissue from Alzheimer's Disease Patients Reveals Candidate Network of Plasma Biomarkers.
    Chen M; Xia W
    J Alzheimers Dis; 2020; 76(1):349-368. PubMed ID: 32474469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common Brain Structural Alterations Associated with Cardiovascular Disease Risk Factors and Alzheimer's Dementia: Future Directions and Implications.
    Lamar M; Boots EA; Arfanakis K; Barnes LL; Schneider JA
    Neuropsychol Rev; 2020 Dec; 30(4):546-557. PubMed ID: 33011894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of cerebrovascular pathology on behavioural and neuropsychiatric symptoms in patients with Alzheimer's dementia: findings from a retrospective, naturalistic study.
    Klugman A; Marshall J; Tabet N
    Int J Clin Pract; 2009 Jul; 63(7):1024-30. PubMed ID: 19570120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central vascular disease and exacerbated pathology in a mixed model of type 2 diabetes and Alzheimer's disease.
    Ramos-Rodriguez JJ; Jimenez-Palomares M; Murillo-Carretero MI; Infante-Garcia C; Berrocoso E; Hernandez-Pacho F; Lechuga-Sancho AM; Cozar-Castellano I; Garcia-Alloza M
    Psychoneuroendocrinology; 2015 Dec; 62():69-79. PubMed ID: 26254770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in brain oxysterols at different stages of Alzheimer's disease: Their involvement in neuroinflammation.
    Testa G; Staurenghi E; Zerbinati C; Gargiulo S; Iuliano L; Giaccone G; Fantò F; Poli G; Leonarduzzi G; Gamba P
    Redox Biol; 2016 Dec; 10():24-33. PubMed ID: 27687218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the AD7C-NTP cDNA expression in Alzheimer's disease and measurement of a 41-kD protein in cerebrospinal fluid.
    Monte SM; Ghanbari K; Frey WH; Beheshti I; Averback P; Hauser SL; Ghanbari HA; Wands JR
    J Clin Invest; 1997 Dec; 100(12):3093-104. PubMed ID: 9399956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insight of brain degenerative protein modifications in the pathology of neurodegeneration and dementia by proteomic profiling.
    Adav SS; Sze SK
    Mol Brain; 2016 Nov; 9(1):92. PubMed ID: 27809929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitotriosidase and inflammatory mediator levels in Alzheimer's disease and cerebrovascular dementia.
    Di Rosa M; Dell'Ombra N; Zambito AM; Malaguarnera M; Nicoletti F; Malaguarnera L
    Eur J Neurosci; 2006 May; 23(10):2648-56. PubMed ID: 16817867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging Interactions between Alzheimer's disease and cerebrovascular disease.
    Wu CC; Mungas D; Eberling JL; Reed BR; Jagust WJ
    Ann N Y Acad Sci; 2002 Nov; 977():403-10. PubMed ID: 12480779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal gene expression in non-demented individuals with intermediate Alzheimer's Disease neuropathology.
    Liang WS; Dunckley T; Beach TG; Grover A; Mastroeni D; Ramsey K; Caselli RJ; Kukull WA; McKeel D; Morris JC; Hulette CM; Schmechel D; Reiman EM; Rogers J; Stephan DA
    Neurobiol Aging; 2010 Apr; 31(4):549-66. PubMed ID: 18572275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease.
    Aliyev A; Chen SG; Seyidova D; Smith MA; Perry G; de la Torre J; Aliev G
    J Neurol Sci; 2005 Mar; 229-230():285-92. PubMed ID: 15760652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.